Cargando…

Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis

It is acknowledged that contrast-induced nephropathy (CIN) is a common cause of acute renal insufficiency after cardiac catheterization and affects mortality and morbidity. To date, it is unknown whether oral N-acetylcysteine (NAC) is able to prevent contrast-induced nephropathy (CIN) in patients un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jing-Xiu, Jin, En-Ze, Yu, Long-Hao, Li, Yang, Liu, Nan-Nan, Dong, Yu-Mei, Li, Xin, Li, Xue-Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525578/ https://www.ncbi.nlm.nih.gov/pubmed/28810622 http://dx.doi.org/10.3892/etm.2017.4678

Ejemplares similares

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy
por: Richter, Sara K., et al.
Publicado: (2015)

Comparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy
por: Arabmomeni, Morteza, et al.
Publicado: (2015)

Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathy
por: Pezeshgi, Aiyoub, et al.
Publicado: (2015)

Prophylaxis of contrast-induced nephropathy in patients with impaired renal function: double-blind comparison of acetylcysteine, theophylline, acetylcysteine + theophylline and placebo
por: Huber, W, et al.
Publicado: (2005)

N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review
por: Jo, Sang-Ho
Publicado: (2011)

Expression of neutrophil gelatinase-associated lipocalin in low osmolar contrast-induced nephropathy in rats and the effect of N-acetylcysteine
por: Li, Wen-Hua, et al.
Publicado: (2016)

Intravenous N-Acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of Randomized, Controlled Trials
por: Sun, Zikai, et al.
Publicado: (2013)

Pentoxifylline and prevention of contrast-induced nephropathy: Is it efficient in patients with myocardial infarction undergoing coronary angioplasty?
por: Eshraghi, Ali, et al.
Publicado: (2016)

Comparison of N-acetylcysteine, ascorbic acid, and normal saline effect in prevention of contrast-induced nephropathy
por: Khaledifar, Arsalan, et al.
Publicado: (2015)

Contrast-induced encephalopathy after coronary angioplasty and stent implantation
por: Yuan, Jun-Liang, et al.
Publicado: (2016)

Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy
Publicado: (2009)

Evaluation of Crocin Effect on Contrast-Induced Nephropathy Following Coronary Angiography or Angioplasty: A Randomized Controlled Trial
por: Shojaei, Lida, et al.
Publicado: (2022)

Predictive factors for contrast-induced acute kidney injury in high-risk patients given N-acetylcysteine prophylaxis
por: Poh, Wei-Yoon, et al.
Publicado: (2018)

Association of N-acetylcysteine use with contrast-induced nephropathy: an umbrella review of meta-analyses of randomized clinical trials
por: Zhu, Rong, et al.
Publicado: (2023)

Acute Kidney Injury After Primary Angioplasty: Is Contrast‐Induced Nephropathy the Culprit?
por: Caspi, Oren, et al.
Publicado: (2017)

N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study
por: Poletti, Pierre-Alexandre, et al.
Publicado: (2013)

Effectiveness of N‐Acetylcysteine for the Prevention of Contrast‐Induced Nephropathy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Xu, Renfan, et al.
Publicado: (2016)

N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients—focus on the antioxidant and anti-inflammatory properties
por: Cepaityte, Dainora, et al.
Publicado: (2023)

Association between plasma endothelial microparticles and contrast-induced nephropathy in patients underwent coronary angiography
por: Fu, Xiaodan, et al.
Publicado: (2021)

The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study
por: Palli, Eleni, et al.
Publicado: (2017)

Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy – a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial
por: Biernacka-Fiałkowska, Barbara, et al.
Publicado: (2018)

Retrospective analysis of the efficacy of radio-contrast-induced nephropathy prophylaxis
por: Wood, J, et al.
Publicado: (2015)

Coronary Angioplasty
por: Louis, Elan Daniel
Publicado: (1988)

Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-analysis
por: Bagshaw, Sean M, et al.
Publicado: (2004)

Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: A systematic review and meta-analysis (PRISMA)
por: Heshmatzadeh Behzadi, Ashkan, et al.
Publicado: (2021)

N-acetylcysteine negatively regulates Notch3 and its malignant signaling
por: Zhang, Xiong, et al.
Publicado: (2016)

Comparison of Oral and Intravenous N-acetyl Cysteine in Preventing Contrast Nephropathy
por: Khatami, Mohammad Reza, et al.
Publicado: (2020)

Acetylcysteine has No Mechanistic Effect in Patients at Risk of Contrast‐Induced Nephropathy: A Failure of Academic Clinical Science
por: Sandilands, Euan A., et al.
Publicado: (2022)

The Impact of Remote Ischemic Pre-Conditioning on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Angioplasty: A Double-Blind Randomized Clinical Trial
por: Gholoobi, Arash, et al.
Publicado: (2015)

N-acetylcysteine ameliorates contrast-induced kidney injury in rats with unilateral hydronephrosis
por: Xia, Qiang, et al.
Publicado: (2018)

Coronary balloon angioplasty /
Publicado: (1994)

Complications of Coronary Angioplasty
por: Desai, Sameer
Publicado: (1992)

Influence of n-acetylcysteine maintenance on the pharmacodynamic effects of oral ethanol
por: Stoops, William W., et al.
Publicado: (2020)

Iodide mumps: A rare complication of iodine-containing contrast after coronary angioplasty
por: Baharvand, Fatemeh, et al.
Publicado: (2020)

N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial
por: Amini, Manouchehr, et al.
Publicado: (2009)

Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency
por: Dósa, Edit, et al.
Publicado: (2017)

Retrospective Analysis of the Clinical Efficacy of N-Acetylcysteine in the Treatment of Hepatitis B Virus Related Acute-on-Chronic Liver Failure
por: Wang, Meng-Lan, et al.
Publicado: (2021)

Safe Contrast Volumes for Preventing Contrast-Induced Nephropathy in Elderly Patients With Relatively Normal Renal Function During Percutaneous Coronary Intervention
por: Liu, Yong, et al.
Publicado: (2015)

Biological Activities and Potential Oral Applications of N-Acetylcysteine: Progress and Prospects
por: Pei, Yanping, et al.
Publicado: (2018)

Sildenafil Citrate for Prophylaxis of Nephropathy in an Animal Model of Contrast-Induced Acute Kidney Injury
por: Lauver, D. Adam, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a42c497uj6vsl0icfpbmsa2i1r